Skip to main content
森萱医药 logo

森萱医药 — Investor Relations & Filings

Ticker · 920946 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 417 across all filing types
Latest filing 2022-03-28 AGM Information
Country CN China
Listing Beijing Stock Exchange 920946

About 森萱医药

https://www.senxuan.cn/

Jiangsu Senxuan Pharmaceutical Co., Ltd. specializes in the research, development, and production of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and specialized fine chemicals. The company’s product portfolio includes key intermediates for antiviral medications, such as those used in the treatment of HIV, and anticonvulsant agents like Primidone. Additionally, it produces high-purity chemical solvents including 1,4-dioxane and 1,3-dioxolane for diverse industrial applications. Senxuan Pharmaceutical maintains a focus on advanced chemical synthesis and large-scale manufacturing capabilities, adhering to international quality standards to support the global life sciences and chemical sectors. Its operations are characterized by a commitment to technical innovation and the supply of critical chemical building blocks for complex therapeutic formulations.

Recent filings

Filing Released Lang Actions
关于召开2021年年度股东大会通知公告（提供网络投票）
AGM Information Classification · 95% confidence The document is a notice announcing the convening of the 2021 Annual General Meeting (AGM) of Jiangsu Senxuan Pharmaceutical Co., Ltd. It details the meeting date, voting methods (including online voting), agenda items to be discussed and voted on, legal compliance, registration procedures, and contact information. It references various reports and proposals that will be reviewed at the AGM but does not contain the reports themselves. The document is about the organization and notification of the AGM rather than the presentation materials or the results of the meeting. Therefore, it fits the category of AGM Information (AGM-R). The document length is about 5403 characters, which is consistent with a detailed AGM notice rather than a full annual report or other filings.
2022-03-28 Chinese
独立董事津贴制度
Remuneration Information Classification · 95% confidence The document is an announcement from Jiangsu Senxuan Pharmaceutical Co., Ltd. regarding the Independent Director Remuneration System. It details the principles, standards, and conditions for paying stipends to independent directors. The document includes procedural information about board approval and submission to the shareholders' meeting. It does not contain financial statements, audit results, or detailed financial performance data. It is not a report but a governance-related announcement about director compensation policies. Therefore, it fits best under Remuneration Information (DEF 14A). The document length is short and focused on remuneration policy, not a full report or announcement of a report publication.
2022-03-28 Chinese
独立董事工作细则
Governance Information Classification · 95% confidence The document is titled '江苏森萱医药股份有限公司独立董事工作细则' which translates to 'Independent Director Work Rules of Jiangsu Senxuan Pharmaceutical Co., Ltd.' It details the internal rules, qualifications, duties, nomination, election, and powers of independent directors in the company. It references relevant laws, regulations, and stock exchange rules, and is a comprehensive governance-related document. There is no financial data, earnings information, or audit content. It is not an announcement of a report but a detailed governance policy document. Therefore, it fits best under Governance Information (CGR). The document length (7312 characters) supports it being a full policy document rather than a brief announcement or notice.
2022-03-28 Chinese
股东大会议事规则
Governance Information Classification · 95% confidence The document is titled '江苏森萱医药股份有限公司股东大会制度' which translates to 'Jiangsu Senxuan Pharmaceutical Co., Ltd. Shareholders' Meeting System'. It details the rules, procedures, and regulations governing the shareholders' meetings, including the rights and responsibilities of shareholders, the powers of the shareholders' meeting, the process for convening meetings, voting procedures, and other governance-related matters. There is no indication that this is an announcement of a meeting, voting results, or a report of financial results. Instead, it is a detailed governance document outlining internal rules and procedures related to the shareholders' meetings. This fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is substantial (over 13,000 characters), indicating it is a full report rather than a brief announcement. Therefore, the appropriate classification is CGR with high confidence.
2022-03-28 Chinese
第三届董事会第十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 14th meeting of the third board of directors of Jiangsu Senxuan Pharmaceutical Co., Ltd. It includes voting results on various proposals such as the 2021 annual reports, financial reports, internal control reports, remuneration, governance rules, and other corporate matters. The document repeatedly mentions that the detailed reports are disclosed separately on the Beijing Stock Exchange information disclosure platform, indicating this document itself is not the full reports but a summary of board decisions. The document is a formal announcement of board meeting resolutions, including management and governance matters, but does not contain full financial statements or detailed financial analysis. Therefore, it fits best into the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management. The document length (9840 characters) and content confirm it is not a brief report publication announcement or a regulatory filing. Hence, the classification is MANG with high confidence.
2022-03-28 Chinese
监事会议事规则
Governance Information Classification · 95% confidence The document is titled as the Supervisory Board System (监事会制度) of Jiangsu Senxuan Pharmaceutical Co., Ltd. It details the rules, powers, composition, meeting procedures, proposal rules, and confidentiality related to the Supervisory Board. There is no financial data, no audit report, no earnings or annual report content, nor any announcement of voting results or management changes. The document is a governance-related internal rules document describing the Supervisory Board's structure and procedures. This fits the definition of Governance Information (CGR). The document length is sufficient and it is not a brief announcement or certification. Therefore, the classification is Governance Information (CGR) with high confidence.
2022-03-28 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.